{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:16:06Z","timestamp":1788189366743,"version":"build-2803163510"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>This Teachable Moment describes a 62-year-old man with thyrotoxicosis due to excess levothyroxine exposure during tirzepatide treatment that induced rapid weight loss.<\/jats:p>","DOI":"10.1001\/jamainternmed.2024.2919","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T15:08:40Z","timestamp":1722870520000},"page":"1246","source":"Crossref","is-referenced-by-count":12,"title":["Tirzepatide-Induced Rapid Weight Loss\u2013Related Thyrotoxicosis"],"prefix":"10.1001","volume":"184","author":[{"given":"Kagan E.","family":"Karakus","sequence":"first","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viral N.","family":"Shah","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halis K.","family":"Akturk","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"itm240003r1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"itm240003r2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018.","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"itm240003r3","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231223991","article-title":"Efficacy and safety of tirzepatide in adults with type 1 diabetes: a proof of concept observational study.","author":"Akturk","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"itm240003r4","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement.","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"19","key":"itm240003r5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2821728\/jamainternal_karakus_2024_tm_240003_1727970839.53244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T15:02:17Z","timestamp":1728313337000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2821728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.2919","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}